Investigational drug · Phase 3
hMG
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Infertility, Infertility (IVF Patients).
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
220
Any phase or sponsor naming "hMG"
First trial start
2025
Nov 1, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "hMG", any sponsor or status.
Conditions studied
As listed on its trial records.
- Infertility
- Infertility (IVF Patients)
Approved drugs for the same conditions: Endocrinology and women's health
Largest trials
Live from ClinicalTrials.gov: studies naming "hMG" as an intervention, largest first.
Canadian Network for Observational Drug Effect Studies, CNODESAcademic, hospital or other
NCT02518516 · 2,067,639 participants · Start Jan 2011 · Primary completion Jan 2013
Drug: Rosuvastatin (≥10 mg); Atorvastatin (≥20 mg) and 6 more · For: Hypercholesterolemia
Sites: Vancouver, Canada
Canadian Network for Observational Drug Effect Studies, CNODESAcademic, hospital or other
NCT02518503 · 136,966 participants · Start Jul 2012 · Primary completion Feb 2013
Drug: Rosuvastatin (≥10 mg); Atorvastatin (≥20 mg) and 7 more · For: Diabetes Mellitus, Type 2; Cardiovascular Disease
Astellas Pharma IncAstellas (ALPMY)
NCT01446679 · 24,050 participants · Start Sep 2010 · Primary completion Mar 2012
Drug: atrovastatin · For: Hypercholesterolemia
Sites: Chugoku, Japan; Chūbu, Japan; Hokkaido, Japan · 8 sites in all
- Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant RecipientsCompleted
Asan Medical CenterAcademic, hospital or other
NCT07089589 · 6,898 participants · Start Jan 2, 2008 · Primary completion Jan 25, 2026
Drug: Preoperative Statin Use · For: Major Adverse Cardiovascular Events; Liver Transplantation
Sites: Seoul, South Korea
- The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian HyperstimulationPivotal-lookingStatus unknown
Peking University People's HospitalAcademic, hospital or other
NCT03809221 · 1,892 participants (planned) · Start Feb 1, 2019 · Primary completion Sep 1, 2020
Drug: Triptorelin acetate · For: Infertility, Female
- Japan Statin Treatment Against Recurrent Stroke (J-STARS)Pivotal-lookingCompleted
Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanAcademic, hospital or other
NCT00221104 · 1,578 participants · Start Mar 1, 2004 · Primary completion Jul 2014
Drug: Pravastatin · For: Ischemic Stroke
Sites: Hiroshima, Japan
- Effects of SNP of GnRH Receptor Genes in IVF PatientsStatus unknown
Miao benyuAcademic, hospital or other
NCT02979886 · 1,500 participants (planned) · Start Jan 2017 · Primary completion Jun 2019
Drug: GnRH-a; Human Menopausal Gonadotropins · For: Infertility, Female
- Statins In Intracerbral HemorrhagePivotal-lookingRecruiting
Beth Israel Deaconess Medical CenterAcademic, hospital or other
NCT03936361 · 1,456 participants (planned) · Start Jun 10, 2020 · Primary completion Dec 31, 2028
Drug: Statins · For: Intracerebral Hemorrhage
Sites: Boston, Massachusetts
- Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT)Pivotal-lookingCompleted
Tokyo UniversityAcademic, hospital or other
NCT00301392 · 1,240 participants · Start Apr 2006 · Primary completion Mar 2012
Drug: Life style interventions plus concomitant use of pitavastatin. · For: Diabetes Mellitus; Glucose Intolerance
Sites: Bunkyo-ku, Japan
Clinical Hospital Centre ZagrebAcademic, hospital or other
NCT05307718 · 1,200 participants (planned) · Start Dec 15, 2020 · Primary completion Dec 14, 2025
Drug: Oral Anticoagulant, Direct-Acting · For: Pharmacogenetics; Drug-Related Side Effects and Adverse Reactions; Cardiovascular Drugs
Sites: Zagreb, Croatia
Newest research
PubMed records naming it or its code names, newest first.
- sox17 Mutagenesis Reveals Compounding Effects ofMaternal and Zygotic Contribution on Microglia Abundance.
Spring CA, Dennen J, Gan D, et al. · Glia 2027
- AA-Induced Lipid Peroxidation at the Center of Tumor Cell Apoptosis and Ferroptosis.
Das UN · Rev Physiol Biochem Pharmacol 2027
- Quantitative and qualitative alteration in intracellular cholesterol status regulates statin sensitivity in non-small-cell lung cancer cells.
Tashiro J, Warita T, Warita K · J Pharmacol Sci 2026
- Ficus elastica phytochemicals mitigate hyperlipidemia via potential HMG-CoA reductase inhibition, reduced oxidative stress, and tissue preservation.
Susanti G, Aldi Y, Handayani D, et al. · Res Pharm Sci 2026
- Follitropin delta versus human menopausal gonadotropin in progestin protocol cycles: a retrospective cohort study using inverse probability of treatment weighting.
Fujii T, Iwami N, Takimoto K, et al. · Eur J Obstet Gynecol Reprod Biol 2026
- Metabolomics-based screening identifies Aspergillus strains that accumulate bioactive leucine catabolites and fatty acid ethyl esters in koji mold-ripened cheese.
Tomita S, Suzuki S, Yamashita H, et al. · Food Res Int 2026
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.